Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and aldosterone

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with aldosterone in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(aldosterone)
Trials
(aldosterone)
Recent Studies (post-2010) (aldosterone)
9,15618755225,3331,5174,169

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)aldosterone (IC50)
Mineralocorticoid receptor Homo sapiens (human)0.0048
Mineralocorticoid receptorRattus norvegicus (Norway rat)0.043

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koyama, Y; Kumahara, Y; Masugi, F; Nagano, M; Ogihara, T; Otsuka, A; Saeki, S; Tabuchi, Y1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and aldosterone

ArticleYear
Hypotensive mechanism of acetyl glyceryl ether phosphorylcholine (AGEPC) in dogs. Effects on hemodynamics and humoral factors.
    Prostaglandins, leukotrienes, and medicine, 1985, Volume: 19, Issue:1

    Topics: Aldosterone; Animals; Antihypertensive Agents; Blood Cells; Blood Pressure; Cardiac Output; Catecholamines; Dogs; Fatty Acids, Unsaturated; Hemodynamics; Hormones; Hydrocortisone; Platelet Activating Factor; Regional Blood Flow; Vasodilation

1985